IGC Pharma, Inc. (IGC)

IGC Pharma Revenue

IGC Pharma had revenue of $257.00K in the quarter ending December 31, 2024, with 25.98% growth. This brings the company's revenue in the last twelve months to $1.24M, up 1.64% year-over-year. In the fiscal year ending March 31, 2024, IGC Pharma had annual revenue of $1.35M with 47.64% growth.

• Revenue (ttm): $1.24M
• Revenue Growth: +1.64%
• P/S Ratio: 18.03
• Revenue / Employee: $18,448
• Employees: 67
• Market Cap: 24.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	1.35M	434.00K	47.64%
Mar 31, 2023	911.00K	514.00K	129.47%
Mar 31, 2022	397.00K	-501.00K	-55.79%
Mar 31, 2021	898.00K	-3.17M	-77.95%
Mar 31, 2020	4.07M	-1.04M	-20.41%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.